MARVIN MANDEL, Governor

2105

(4D)	DIAZEPAM;
(5)	Ethinamate;
(5A)	FLURAZEPAM;
(53)	MEBUTAMATE;
(6)	Methohexital;
(7)	Meprobamate;
(8)	Methylphenobarbital;
(8A)	OXAZEPAM;
(9)	Paraldehyde;
(10)	Petrichloral;
(11)	Phenobarbital;

B.    ANY MATERIAL, COMPOUND, MIXTURE, OR PREPARATION
WHICH CONTAINS ANY QUANTITY OF THE FOLLOWING SUBSTANCES
INCLUDING ITS SALTS, ISOMERS (WHETHER OPTICAL, POSITION,
OR GEOMETRIC) , AND SALTS OF SUCH ISOMERS WHENEVER THE
EXISTENCE OF SUCH SALTS, ISOMERS, AND SALTS OF ISOMERS IS
POSSIBLE:

(1) FENFLURAMINE.

C.    ANY MATERIAL, COMPOUND, MIXTURE, OR   PREPARATION
WHICH CONTAINS ANY QUANTITY OF THE FOLLOWING     SUBSTANCES
HAVING A POTENTIAL FOR ABUSE ASSOCIATED WITH   A STIMULANT
EFFECT ON THE CENTRAL NERVOUS SYSTEM:

(1)          DIETHYLPROPION.

(2)    PEMOLINE (INCLUDING ORGANOMETALLIC
COMPLEXES AND CHELATES THEREOF).

(3)    PHENTERMINE.

[b.]D. The Department may except by rule any
compound, mixture, or preparation containing any
depressant substance listed in subsection (a) from the
application of all or any part of this act if the
compound, mixture, or preparation contains one or more
active medicinal ingredients not having a depressant
effect on the central nervous system, and if the
admixtures are included therein in combinations,
quantity, proportion, or concentration that vitiate the
potential for abuse of the substances which have a
depressant effect on the central nervous system.

(e) SCHEDULE V — In determining that a substance
comes within this schedule, the Department shall find: